Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Cellular Immunology
|
October 5, 2021
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice
Arthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Cellular Immunology
|
June 23, 2022
"Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct
Arthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Frontiers in Immunology
|
May 27, 2025
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
Aviran Aharon, Batia Avni, Daniel Louzoun, et al.
Translational Stroke Research
|
December 19, 2016
DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury
Jianyi Wang, Qing Ye, Jing Xu, et al.
Journal of Neuroimmunology
|
August 6, 2017
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells
Gil Benedek, Jun Zhang, Ha Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis
Roberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Metabolic Brain Disease
|
March 18, 2017
DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury
Liu Yang, Zhijia Liu, Honglei Ren, et al.
Plos Neglected Tropical Diseases
|
July 9, 2020
Protection or susceptibility to devastating childhood epilepsy: Nodding Syndrome associates with immunogenetic fingerprints in the HLA binding groove
Gil Benedek, Mahmoud Abed El Latif, Keren Miller, et al.
Plos Neglected Tropical Diseases
|
October 18, 2021
Macrophage migration inhibitory factor in Nodding syndrome
Gil Benedek, Mahmoud Abed El Latif, Keren Miller, et al.
Journal of Autoimmunity
|
October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance
Arthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Cellular Immunology
|
October 5, 2021
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice
Arthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Cellular Immunology
|
June 23, 2022
"Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct
Arthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Frontiers in Immunology
|
May 27, 2025
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
Aviran Aharon, Batia Avni, Daniel Louzoun, et al.
Translational Stroke Research
|
December 19, 2016
DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury
Jianyi Wang, Qing Ye, Jing Xu, et al.
Journal of Neuroimmunology
|
August 6, 2017
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells
Gil Benedek, Jun Zhang, Ha Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis
Roberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Metabolic Brain Disease
|
March 18, 2017
DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury
Liu Yang, Zhijia Liu, Honglei Ren, et al.
Plos Neglected Tropical Diseases
|
July 9, 2020
Protection or susceptibility to devastating childhood epilepsy: Nodding Syndrome associates with immunogenetic fingerprints in the HLA binding groove
Gil Benedek, Mahmoud Abed El Latif, Keren Miller, et al.
Plos Neglected Tropical Diseases
|
October 18, 2021
Macrophage migration inhibitory factor in Nodding syndrome
Gil Benedek, Mahmoud Abed El Latif, Keren Miller, et al.
Journal of Autoimmunity
|
October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance
Arthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Page
of 4